GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians.

GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training of a new generation of glyco-scientists and entrepreneurs. The network includes over 170 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.

GlycoNet is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.

Network Investigators
Trained HQP
Funded Projects
Network Partners

Latest News

Glycomics: The New Frontier in Bioinnovation

In our new report: Why glycomics is at the centre of a new surge of scientific and industry interest.

confocal image of a microglia cell in homeostatic conditions
Making strides in Alzheimer’s research

GlycoNet researchers have made exciting advances in understanding Alzheimer’s disease and are developing a potential therapeutic strategy.

Top 10 Stories 2021
Top 10 stories from GlycoNet in 2021

A year in review in glycomics innovations.

Network Members

Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tel: 780-492-6204
Fax: 780-492-4147

Subscribe to GlycoNet’s Newsletter


Scroll to Top